Oxurion NV: Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
Source: finanznachrichten.de
Page 10 - Bedema News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bedema. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bedema Today - Breaking & Trending Today
MyJournals.org - Science - 'Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema' (BMC Ophthalmology)
MyJournals.org - Science - 'Predictive effect of TCED-HFV grading and imaging biomarkers on anti-VEGF therapy in diabetic macular edema' (BMC Ophthalmology)
Source: myjournals.org
FDA Approves New Indication for Avapritinib
Avapritinib (AYVAKIT) is now approved to treat adults with indolent systemic mastocytosis.
Source: medscape.com
Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops
DIAMOND trial in Diabetic Macular Edema with topical OCS-01 met its stage 1 objective of validating the loading and maintenance dosing regimen designed to optimize OCS-01 efficacy potential with... | May 22, 2023
Source: marketscreener.com
AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007 for Age-Related Macular Degeneration and Diabetic Macular Edema
Novel JEL Technology for Periocular Administration COSTA MESA, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has begun a
Source: finanznachrichten.de